ZFAS1 and central nervous system cancer: Aberrant high expression of ZFAS1 was reported in a series of human cancers, including hepatocellular carcinoma [14], gastric cancer [15–17], melanoma [18], lung cancer [19], glioma [20] and colorectal cancer [21–23].